AbilityPharma awarded €5 million from the Horizon Europe EIC Accelerator Pilot Program to conduct a Phase 2b clinical trial with ABTL0812 in patients with advanced pancreatic cancer

by Ability Pharma

4 years ago
Inveready, Everis, Sodena, Ability Pharma, BEI, drug, financing, PancreaticCancer

The biopharmaceutical company Ability Pharmaceuticals SL announced today that it has been awarded €5 million blended financing from the Horizon Europe, European Innovation Council (EIC) Accelerator ...

Paving the Way to Expand the Uses of Ivermectin

by ISGlobal - Instituto de Salud Global de Barcelona

4 years ago
scabies, drug, malaria, ivermectin

A systematic review and meta-analysis adds evidence to the safety of using ivermectin at higher doses than those currently recommended

Minoryx Therapeutics receives US FDA fast-track designation for leriglitazone in the treatment of X-ALD

by Minoryx Therapeutics

4 years ago
Central Nervous System, drug, Friedreich’s Ataxia, neuroscience

Leriglitazone (MIN-102), a novel, brain penetrant, orally bioavailable and selective PPARγ agonist, is currently in late-stage development for treatment of severe orphan CNS disorders, including X-AL...

Minoryx Therapeutics receives FDA Orphan Drug Designation for leriglitazone in Friedreich’s Ataxia

by Minoryx Therapeutics

4 years ago
neurodegenerative disease, Friedreich’s Ataxia, FDA, drug

Leriglitazone (MIN-102) is a novel, brain penetrant, orally bioavailable and selective PPARγ agonist Second Orphan Drug Designation granted by the FDA for leriglitazone in addition to X-linked adr...

Antimicrobial Resistance: A Threat that Calls for Non-Conventional Strategies

by ISGlobal - Instituto de Salud Global de Barcelona

5 years ago
drug, antimicrobial, Resistance

ISGlobal researchers publish a review on the most promising strategies and organise, in collaboration with Biocat and “la Caixa”, a B-debate on the topic

A new study considers methadone to be the most appropriate non-addictive opioid drug to treat chronic pain

by Universitat de Barcelona

5 years ago
methadone, opioid, drug, chronic, pain

Administrating methadone instead of morphine is he most indicated pharmacological treatment in the fight against chronic pain, according to a new article published in the Journal of Clinical Inv...

FDA aims to start deactivating outdated drug listing records to ensure the patient safety

by Asphalion

5 years ago
FDA, drug, patient safety

The Food and Drug Administration (FDA) announced its intention to clean the drug listing database from outdated and uncertified records. This action is not limited only to listings for finished dru...

New gene therapy for autosomal dominant retinitis pigmentosa

by DBGen Ocular Genomics

5 years ago
gene therapy, retinitis, drug, dystrophy

The United States Food and Drug Administration (FDA) has just approved the designation of the QR-1123 therapy by the Dutch company ProQR as a new investigational drug. This drug aims to treat a form o...

AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury

by Ysios Capital

5 years ago
Ysios Capital, AM-Pharma, acute kidney injury, drug

AM-Pharma B.V. (‘AM-Pharma, the Company’), a clinical stage biopharmaceutical company, leading in the development of a treatment for acute kidney injury (AKI) with its innovative recombinant human...

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer

by Pivotal

5 years ago
Pivotal, clinical trials, drug, melanoma, lung cancer

Pivotal, a specialist CRO, has been awarded two clinical trials for a novel investigational immunotherapy drug and patient enrolment has now started. Pivotal will use its deep knowledge of Oncology...

Sant Pau develops a drug that destroys metastatic cells with cancer without harming the healthy ones

by Hospital de la Santa Creu i Sant Pau

5 years ago
drug, metastatic cells, cancer, nanometric-sized, Clinical Trial, Health Technologies

The Oncogenesis and Antitumor Research Group, from the Research Institute of the Hospital de Sant Pau-IIB Sant Pau, led by Dr. Ramon Mangues, has developed the first nanometric-sized drug that is sele...

Researchers discover the mechanism of action of an antitumour drug used for the treatment of glioblastoma

by IRB Barcelona - Instituto de Investigación Biomédica

5 years ago
epidermal, drug, glioblastoma

The antibody mAb806 is used to treat glioblastoma, although its mechanism of action has been unknown until now. The study, published in the journal PNAS, paves the way to extend treatment with mAb806 ...